Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin A Lewis

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of the American College of Cardiology|March 11, 2017
Outcome Measures in HFpEF Trials: Should We Refocus?Gavin A Lewis, Christopher A Miller
Circulation|March 15, 2017
Letter by Lewis and Miller Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection Fraction"Gavin A Lewis, Christopher A Miller
The New England Journal of Medicine|March 19, 2020
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionGavin A Lewis, Erik B Schelbert, Christopher A Miller
Journal of the American College of Cardiology|January 25, 2020
Beyond Valvular Heart DiseaseChristopher A Miller, Gavin A Lewis, Simon G Ray
Circulation|March 21, 2018
Letter by Lewis et al Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)"Gavin A Lewis, Erik B Schelbert, Christopher A Miller
Journal of the American College of Cardiology|November 13, 2020
Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEFGavin A Lewis, Erik B Schelbert, Karl E Kadler, et al.
Heart Failure Reviews|November 6, 2020
The utility of cardiovascular imaging in heart failure with preserved ejection fraction: diagnosis, biological classification and risk stratificationGavin A Lewis, Keith Pearce, Simon G Williams, et al.
JACC. Cardiovascular Imaging|August 19, 2019
Considerations for Clinical Trials Targeting the Myocardial InterstitiumGavin A Lewis, Susanna Dodd, Josephine H Naish, et al.
Journal of the American College of Cardiology|October 21, 2017
Biological Phenotypes of Heart Failure With Preserved Ejection FractionGavin A Lewis, Erik B Schelbert, Simon G Williams, et al.
Journal of Cardiovascular Translational Research|July 5, 2022
Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure with Preserved Ejection FractionGavin A Lewis, Anna Rosala-Hallas, Susanna Dodd, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of the American College of Cardiology|March 11, 2017
Outcome Measures in HFpEF Trials: Should We Refocus?Gavin A Lewis, Christopher A Miller
Circulation|March 15, 2017
Letter by Lewis and Miller Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection Fraction"Gavin A Lewis, Christopher A Miller
The New England Journal of Medicine|March 19, 2020
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionGavin A Lewis, Erik B Schelbert, Christopher A Miller
Journal of the American College of Cardiology|January 25, 2020
Beyond Valvular Heart DiseaseChristopher A Miller, Gavin A Lewis, Simon G Ray
Circulation|March 21, 2018
Letter by Lewis et al Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)"Gavin A Lewis, Erik B Schelbert, Christopher A Miller
Journal of the American College of Cardiology|November 13, 2020
Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEFGavin A Lewis, Erik B Schelbert, Karl E Kadler, et al.
Heart Failure Reviews|November 6, 2020
The utility of cardiovascular imaging in heart failure with preserved ejection fraction: diagnosis, biological classification and risk stratificationGavin A Lewis, Keith Pearce, Simon G Williams, et al.
JACC. Cardiovascular Imaging|August 19, 2019
Considerations for Clinical Trials Targeting the Myocardial InterstitiumGavin A Lewis, Susanna Dodd, Josephine H Naish, et al.
Journal of the American College of Cardiology|October 21, 2017
Biological Phenotypes of Heart Failure With Preserved Ejection FractionGavin A Lewis, Erik B Schelbert, Simon G Williams, et al.
Journal of Cardiovascular Translational Research|July 5, 2022
Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure with Preserved Ejection FractionGavin A Lewis, Anna Rosala-Hallas, Susanna Dodd, et al.
Pageof 2